BioCentury
ARTICLE | Company News

Evotec, Jain Foundation deal

November 17, 2014 8:00 AM UTC

Evotec and Jain extended and expanded their 2012 deal to develop a cell-based high throughput screening assay using dysferlin ( DYSF)-deficient cells to identify compounds to treat dysferlinopathy. U...